Assignee
REALTA HOLDINGS LLC
US·11 granted patents·12 pending applications·40 citations·filing 2016–2025
Top patents by PatentIndex Score
23 records- 0195US12257290B2PIC1 inhibition of myeloperoxidase oxidative activity in an animal modelREALTA HOLDINGS LLC·Filed 2023·Granted Mar 25, 2025·1 cites·10 claims
- 0295US11020460B2PIC1 inhibition of myeloperoxidase oxidative activity in an animal modelREALTA HOLDINGS LLC·Filed 2020·Granted Jun 1, 2021·4 cites·22 claims
- 0395US10844093B2Peptide compounds to regulate the complement systemREALTA HOLDINGS LLC·Filed 2019·Granted Nov 24, 2020·5 cites·10 claims
- 0495US10005818B2Derivative peptide compounds and methods of useREALTA HOLDINGS LLC·Filed 2016·Granted Jun 26, 2018·12 cites·13 claims
- 0593US12297235B2Synthetic peptide compounds and methods of useREALTA HOLDINGS LLC·Filed 2023·Granted May 13, 2025·1 cites·13 claims
- 0692US2026021164A1Pic1 inhibition of myeloperoxidase oxidative activity in an animal modelREALTA HOLDINGS LLC·Filed 2025·Application pending·0 cites
- 0792US2026028373A1Peptide compounds to regulate the complement systemREALTA HOLDINGS LLC·Filed 2025·Application pending·0 cites
- 0891US10414799B2Peptide compounds to regulate the complement systemREALTA HOLDINGS LLC·Filed 2018·Granted Sep 17, 2019·5 cites·30 claims
- 0990US10933116B2Synthetic peptide compounds and methods of useREALTA HOLDINGS LLC·Filed 2016·Granted Mar 2, 2021·5 cites·8 claims
- 1090US2024309047A1Peptide compounds to regulate the complement systemREALTA HOLDINGS LLC·Filed 2024·Application pending·0 cites
- 1188US11814414B2Synthetic peptide compounds and methods of useREALTA HOLDINGS LLC·Filed 2021·Granted Nov 14, 2023·1 cites·10 claims
- 1288US11712462B2PIC1 inhibition of myeloperoxidase oxidative activity in an animal modelREALTA HOLDINGS LLC·Filed 2021·Granted Aug 1, 2023·1 cites·18 claims
- 1388US11135272B2PIC1 inhibition of myeloperoxidase oxidative activity in an animal modelREALTA HOLDINGS LLC·Filed 2019·Granted Oct 5, 2021·4 cites·20 claims
- 1485US10947279B2Synthetic peptide compounds and methods of useREALTA HOLDINGS LLC·Filed 2019·Granted Mar 16, 2021·1 cites·11 claims
- 1584US2023151058A1Peptide compounds to regulate the complement systemREALTA HOLDINGS LLC·Filed 2022·Application pending·0 cites
- 1681US2022127306A1Peptide compounds to regulate the complement systemREALTA HOLDINGS LLC·Filed 2022·Application pending·0 cites
- 1779US2025177492A1Pic1 inhibition of myeloperoxidase oxidative activity in an animal modelREALTA HOLDINGS LLC·Filed 2025·Application pending·0 cites
- 1878US2021292366A1Peptide compounds to regulate the complement systemREALTA HOLDINGS LLC·Filed 2021·Application pending·0 cites
- 1976US2021047371A1Peptide compounds to regulate the complement systemREALTA HOLDINGS LLC·Filed 2020·Application pending·0 cites
- 2054US2019010193A1Derivative Peptide Compounds and Methods of UseREALTA HOLDINGS LLC·Filed 2018·Application pending·0 cites
- 2151US2022249596A1Pic1 peptide compositions and methods of use thereof for treatment of hypoxic ischemic encephalopathyREALTA HOLDINGS LLC·Filed 2020·Application pending·0 cites
- 2250US2022096592A1Pic1 variants with improved solubility and methods of using the sameREALTA HOLDINGS LLC·Filed 2020·Application pending·0 cites
- 2346US2021228695A1Pic1 peptide compositions and methods of use thereof for treatment of drug-induced immune hemolytic anemiaREALTA HOLDINGS LLC·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when REALTA HOLDINGS LLC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →